Molecular Dissection of 17q12 Amplicon in Upper Gastrointestinal Adenocarcinomas
Open Access
- 18 July 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 4 (7), 449-455
- https://doi.org/10.1158/1541-7786.mcr-06-0058
Abstract
DNA amplification at 17q is frequently detected in upper gastrointestinal adenocarcinomas (UGC; stomach and esophagus). In this study, we did fluorescence in situ hybridization on a tissue microarray that contained 304 UGCs and 89 normal stomach samples using a ∼168-kb BAC clone (CTD-2019C10) that maps to 17q12-q21.1. This 168-kb region contains the following genes: PPP1R1B/DARPP-32, STARD3, TCAP, PNMT, PERLD1, ERBB2, C17orf37, and GRB7 as well as the first two exons of ZNFN1A3. DNA amplification (≥5 signals) was detected in 85 of 282 (30%) of UGCs, and high-level amplification (≥10 signals) was seen in 28 of 282 (10%) of all tumors. Adenocarcinomas of gastroesophageal junction and lower esophagus had the highest frequency of amplification (45%) compared with stomach tumors (27%; P = 0.04). On the other hand, 38% of tumors with intestinal-type morphology had amplification compared with 26% of diffuse-type tumors (P = 0.02). We further did quantitative real-time reverse transcription-PCR on 74 frozen tissue samples from UGCs for 11 genes located within or adjacent to the boundaries of this ∼168-kb genomic region. These genes include all 9 genes that are fully or partially located inside the CTD-2019C10 clone as well as 2 additional adjacent genes (NEUROD and TOP2A). Overexpression of PPP1R1B/DARPP-32, TCAP, and TOP2A was seen in approximately half of the tumors, whereas STARD3 and ZNFN1A3 were rarely overexpressed (12%). Interestingly, there was a statistical correlation between expression of all 8 genes that map between PPP1R1B/DARPP-32 and GRB7, whereas expression of NEUROD, ZNFN1A3, and TOP2A that are partially inside or adjacent to the boundaries of the CTD-2019C10 clone did not correlate with the expression of any of these 8 genes. These data show a transcriptionally active oncogenomic region bounded by PPP1R1B/DARPP-32 and GRB7 in UGCs and provide further insight into expression levels of several critical genes. (Mol Cancer Res 2006;4(7):449–55)Keywords
This publication has 42 references indexed in Scilit:
- Expression of HER2 and the Coamplified Genes GRB7 and MLN64 in Human Breast Cancer: Quantitative Real-time Reverse Transcription-PCR as a Diagnostic Alternative to Immunohistochemistry and Fluorescence In situ HybridizationClinical Cancer Research, 2005
- Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancerBreast Cancer Research and Treatment, 2005
- Neoadjuvant Therapy With Trastuzumab, Paclitaxel and Epirubicin for HER-2–Positive Operable Breast CancerJournal of Clinical Oncology, 2005
- Darpp-32: a Novel Antiapoptotic Gene in Upper Gastrointestinal CarcinomasCancer Research, 2005
- Coamplified and overexpressed genes at ERBB2 locus in gastric cancerInternational Journal of Cancer, 2004
- HER‐2 and TOP2A coamplification in urinary bladder cancerInternational Journal of Cancer, 2003
- Overexpression of the 32‐kilodalton dopamine and cyclic adenosine 3′,5′‐monophosphate‐regulated phosphoprotein in common adenocarcinomasCancer, 2003
- Frequent amplification of 8q24, 11q, 17q, and 20q‐specific genes in pancreatic cancerGenes, Chromosomes and Cancer, 2002
- The changing spectrum of gastroesophageal reflux diseaseEuropean Journal Of Cancer Prevention, 2002
- The Human Genome Browser at UCSCGenome Research, 2002